financetom
Business
financetom
/
Business
/
Kinsale Capital Group Insider Sold Shares Worth $443,110, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kinsale Capital Group Insider Sold Shares Worth $443,110, According to a Recent SEC Filing
Jul 31, 2024 2:11 PM

04:54 PM EDT, 07/31/2024 (MT Newswires) -- Anne C. Kronenberg, Director, on July 30, 2024, sold 1,000 shares in Kinsale Capital Group ( KNSL ) for $443,110. Following the Form 4 filing with the SEC, Kronenberg has control over a total of 8,039 shares of the company, with 8,039 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1669162/000171548324000002/xslF345X03/wk-form4_1722456424.xml

Price: 455.00, Change: -2.07, Percent Change: -0.45

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Microsoft Implores Trump to Overhaul Limits on AI Chip Exports
Market Chatter: Microsoft Implores Trump to Overhaul Limits on AI Chip Exports
Feb 27, 2025
08:01 AM EST, 02/27/2025 (MT Newswires) -- Microsoft ( MSFT ) is set to release a blog post Thursday that will call for the Trump administration to ease limits on chips that can be used in data centers for training artificial intelligence models, The Wall Street Journal reported Thursday, citing company officials. Specifically, the company wants to ensure the limits...
Payoneer Global Q4 Earnings Decrease; Revenue Increases; 2025 Outlook Issued
Payoneer Global Q4 Earnings Decrease; Revenue Increases; 2025 Outlook Issued
Feb 27, 2025
08:02 AM EST, 02/27/2025 (MT Newswires) -- Payoneer Global ( PAYO ) reported Q4 earnings Thursday of $0.05 per diluted share, down from $0.07 a year earlier. Analysts polled by FactSet expected $0.06. Revenue for the quarter ended Dec. 31 was $261.7 million, up from $224.3 million a year earlier. Analysts surveyed by FactSet expected $241.3 million. For 2025, the...
Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines
Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines
Feb 27, 2025
Feb 27 (Reuters) - Novavax's ( NVAX ) fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 vaccines, its only product on the market. The company has struggled to keep up with the pace of its rivals Moderna ( MRNA ) and Pfizer ( PFE ), which make messenger RNA-based vaccines compared to its protein-based...
Macerich Q4 Adjusted Funds From Operations Fall; Revenue Rises
Macerich Q4 Adjusted Funds From Operations Fall; Revenue Rises
Feb 27, 2025
08:01 AM EST, 02/27/2025 (MT Newswires) -- Macerich ( MAC ) reported Q4 adjusted funds from operations Thursday of $0.47 per diluted share, down from $0.57 a year earlier. Revenue for the quarter ended Dec. 31 was $273.7 million compared with $238.7 million a year earlier. Analysts surveyed by FactSet expected $222.2 million. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved